JP2017503753A5 - - Google Patents
Download PDFInfo
- Publication number
- JP2017503753A5 JP2017503753A5 JP2016532025A JP2016532025A JP2017503753A5 JP 2017503753 A5 JP2017503753 A5 JP 2017503753A5 JP 2016532025 A JP2016532025 A JP 2016532025A JP 2016532025 A JP2016532025 A JP 2016532025A JP 2017503753 A5 JP2017503753 A5 JP 2017503753A5
- Authority
- JP
- Japan
- Prior art keywords
- alkyl
- group
- pharmaceutically acceptable
- acceptable salt
- compound according
- Prior art date
- Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
- Granted
Links
- 0 *C(C1)C(CC=C)OC(*)C1=O Chemical compound *C(C1)C(CC=C)OC(*)C1=O 0.000 description 1
Priority Applications (1)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| JP2019125655A JP6929903B2 (ja) | 2013-11-19 | 2019-07-05 | 抗癌剤およびその調製方法 |
Applications Claiming Priority (3)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| US201361906133P | 2013-11-19 | 2013-11-19 | |
| US61/906,133 | 2013-11-19 | ||
| PCT/US2014/066458 WO2015077370A1 (en) | 2013-11-19 | 2014-11-19 | Anti-cancer agents and preparation thereof |
Related Child Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| JP2019125655A Division JP6929903B2 (ja) | 2013-11-19 | 2019-07-05 | 抗癌剤およびその調製方法 |
Publications (3)
| Publication Number | Publication Date |
|---|---|
| JP2017503753A JP2017503753A (ja) | 2017-02-02 |
| JP2017503753A5 true JP2017503753A5 (https=) | 2017-12-28 |
| JP6937578B2 JP6937578B2 (ja) | 2021-09-22 |
Family
ID=53180106
Family Applications (2)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| JP2016532025A Active JP6937578B2 (ja) | 2013-11-19 | 2014-11-19 | 抗癌剤およびその調製方法 |
| JP2019125655A Active JP6929903B2 (ja) | 2013-11-19 | 2019-07-05 | 抗癌剤およびその調製方法 |
Family Applications After (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| JP2019125655A Active JP6929903B2 (ja) | 2013-11-19 | 2019-07-05 | 抗癌剤およびその調製方法 |
Country Status (20)
| Country | Link |
|---|---|
| US (1) | US10000505B2 (https=) |
| EP (1) | EP3071563B1 (https=) |
| JP (2) | JP6937578B2 (https=) |
| KR (1) | KR102428737B1 (https=) |
| CN (3) | CN113461705A (https=) |
| AU (1) | AU2014353087B2 (https=) |
| BR (1) | BR112016011430B1 (https=) |
| CA (1) | CA2931111C (https=) |
| CL (1) | CL2016001209A1 (https=) |
| DK (1) | DK3071563T3 (https=) |
| EA (1) | EA035262B1 (https=) |
| ES (1) | ES2943711T3 (https=) |
| FI (1) | FI3071563T3 (https=) |
| IL (2) | IL282430B2 (https=) |
| MX (1) | MX375896B (https=) |
| MY (1) | MY189459A (https=) |
| PE (1) | PE20161240A1 (https=) |
| PH (2) | PH12021551085A1 (https=) |
| PT (1) | PT3071563T (https=) |
| WO (1) | WO2015077370A1 (https=) |
Families Citing this family (8)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| CN113461705A (zh) * | 2013-11-19 | 2021-10-01 | 普渡研究基金会 | 抗癌剂及其制备 |
| AU2017277786A1 (en) | 2016-06-08 | 2019-01-03 | William Marsh Rice University | Derivatives of Thailanstatin A, methods of treatment and methods of synthesis thereof |
| JP7111722B2 (ja) * | 2016-09-23 | 2022-08-02 | パーデュー・リサーチ・ファウンデーション | 抗がん剤およびその調製方法 |
| IL273387B2 (en) | 2017-09-20 | 2023-10-01 | Ph Pharma Co Ltd | Thylanstatin analogs |
| CN109020876A (zh) * | 2018-09-21 | 2018-12-18 | 大连理工大学 | 一种新型6-羟基-2h-二氢吡啶-3-酮的制备方法 |
| PE20211473A1 (es) | 2018-12-13 | 2021-08-05 | Eisai Randd Man Co Ltd | Conjugados de anticuerpo-farmaco de herboxidieno y metodos de uso |
| US20230159552A1 (en) * | 2020-04-09 | 2023-05-25 | Bristol-Myers Squibb Company | Meayamycin and its analogues, methods for their preparation, and methods of use |
| CN113563361B (zh) * | 2021-08-17 | 2022-05-20 | 浙江珲达生物科技有限公司 | 一种从伯克霍尔德菌发酵液提取fr901464的方法 |
Family Cites Families (7)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| FR901464A (fr) | 1943-01-23 | 1945-07-27 | Boehringer & Soehne Gmbh | Procédé d'obtention de vanilline |
| US7825267B2 (en) * | 2006-09-08 | 2010-11-02 | University Of Pittsburgh-Of The Commonwealth System Of Higher Education | Synthesis of FR901464 and analogs with antitumor activity |
| NZ602675A (en) | 2008-03-18 | 2014-03-28 | Genentech Inc | Combinations of an anti-her2 antibody-drug conjugate and chemotherapeutic agents, and methods of use |
| AR080234A1 (es) * | 2010-02-25 | 2012-03-21 | Marrone Bio Innovations Inc | Cepa bacteriana aislada del genero burkholderia y metabolitos pesticidas del mismo |
| IN2014MN00242A (https=) * | 2011-08-27 | 2015-09-25 | Marrone Bio Innovations Inc | |
| MX340090B (es) * | 2012-11-05 | 2016-06-23 | Pfizer | Analogos de spliceostatina. |
| CN113461705A (zh) | 2013-11-19 | 2021-10-01 | 普渡研究基金会 | 抗癌剂及其制备 |
-
2014
- 2014-11-19 CN CN202110798232.6A patent/CN113461705A/zh active Pending
- 2014-11-19 BR BR112016011430-2A patent/BR112016011430B1/pt active IP Right Grant
- 2014-11-19 KR KR1020167016232A patent/KR102428737B1/ko active Active
- 2014-11-19 CN CN201480070416.9A patent/CN105829299A/zh active Pending
- 2014-11-19 MX MX2016006591A patent/MX375896B/es active IP Right Grant
- 2014-11-19 PH PH1/2021/551085A patent/PH12021551085A1/en unknown
- 2014-11-19 US US15/038,027 patent/US10000505B2/en active Active
- 2014-11-19 CA CA2931111A patent/CA2931111C/en active Active
- 2014-11-19 MY MYPI2016000932A patent/MY189459A/en unknown
- 2014-11-19 IL IL282430A patent/IL282430B2/en unknown
- 2014-11-19 EP EP14863201.1A patent/EP3071563B1/en active Active
- 2014-11-19 PT PT148632011T patent/PT3071563T/pt unknown
- 2014-11-19 WO PCT/US2014/066458 patent/WO2015077370A1/en not_active Ceased
- 2014-11-19 ES ES14863201T patent/ES2943711T3/es active Active
- 2014-11-19 PE PE2016000653A patent/PE20161240A1/es unknown
- 2014-11-19 DK DK14863201.1T patent/DK3071563T3/da active
- 2014-11-19 AU AU2014353087A patent/AU2014353087B2/en active Active
- 2014-11-19 CN CN202110798234.5A patent/CN113773333A/zh active Pending
- 2014-11-19 JP JP2016532025A patent/JP6937578B2/ja active Active
- 2014-11-19 FI FIEP14863201.1T patent/FI3071563T3/fi active
- 2014-11-19 EA EA201691010A patent/EA035262B1/ru not_active IP Right Cessation
-
2016
- 2016-05-15 IL IL245637A patent/IL245637B/en active IP Right Grant
- 2016-05-19 PH PH12016500924A patent/PH12016500924A1/en unknown
- 2016-05-19 CL CL2016001209A patent/CL2016001209A1/es unknown
-
2019
- 2019-07-05 JP JP2019125655A patent/JP6929903B2/ja active Active
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| JP2017503753A5 (https=) | ||
| MX2022008066A (es) | Compuestos triciclicos sustituidos. | |
| PH12018550049A1 (en) | Protein kinase inhibitor, preparation method and medical use thereof | |
| JP2012530779A5 (https=) | ||
| RU2012101947A (ru) | Способы лечения и профилактики усталости | |
| JP2010138190A5 (https=) | ||
| MX2013012588A (es) | Inhibidores de cinasa. | |
| CA2637765A1 (en) | Benzamide and heteroarene derivatives | |
| EA202092671A1 (ru) | Оптимизированная комбинированная терапия и ее применение для лечения злокачественной опухоли и аутоиммунного заболевания | |
| RU2005109913A (ru) | Азабициклоалкильные эфиры и их применение в качестве агонистов альфа7-nachr | |
| JP2015535247A5 (https=) | ||
| JP2017524742A (ja) | テトラヒドロキノリン誘導体の調製のための合成中間体の調製方法 | |
| JP2014524476A5 (https=) | ||
| JOP20250057A1 (ar) | مركبات لعلاج السرطان | |
| JP2017214400A (ja) | （＋）−１，４−ジヒドロ−７−［（３ｓ，４ｓ）−３−メトキシ−４−（メチルアミノ）−１−ピロリジニル］−４−オキソ−１−（２−チアゾリル）−１，８−ナフチリジン−３−カルボン酸の製造方法 | |
| BR112022010181A2 (pt) | Composto tri-heterocíclico como inibidor de jak e uso do mesmo | |
| EP4585269A3 (en) | Methods for cancer therapy | |
| NO20061319L (no) | 5-arylpyrimidiner som anticancer legemidler | |
| EP2144886A1 (en) | Method of treating melanoma | |
| JP2017516829A5 (https=) | ||
| JP2013525290A5 (https=) | ||
| JP2018140987A5 (https=) | ||
| RU2010120810A (ru) | Гидратированные кристаллические сложные эфиры камптотецина для лечения рака | |
| US10093609B2 (en) | TAK1 kinase inhibitors, compositions, and uses related thereto | |
| JP2015512404A5 (https=) |